ArticleBioinformatics (Oxford, England)2026
HybridGNN: a graph neural network approach for human miRNA-disease association prediction.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- RGCNMDA: pathway-bridged relational graph learning with adaptive multi-view fusion for human miRNA-disease association prediction.Bioinformatics (Oxford, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
motivationMicroRNAs (miRNAs) are small non-coding RNAs, typically 18-24 nucleotides in length, that play a pivotal role in RNA silencing and the post-transcriptional regulation of gene expression by targeting messenger RNAs (mRNAs). Dysregulation of these miRNAs has consistently been implicated in the onset and progression of a variety of complex human diseases.
resultsIn this study, we propose a novel HybridGNN model that integrates a Graph Convolutional Network (GCN), a Graph Attention Network (GAT), and Matrix Decomposition with Matrix Factorization (MDMF) to predict potential miRNA-disease associations (MDAs). We incorporate five types of similarity in which three are derived from miRNAs and two are derived from diseases, to comprehensively explore and optimize multi-source feature information. The complementary interactions among these modules also help to mitigate the oversmoothing problem. The model utilizes neighboring nodes in a heterogeneous network to generate node embeddings via a message-passing mechanism. To improve computational efficiency, we employ a mini-batch gradient descent approach that partitions the graph into smaller sub-graphs, thereby enhancing the model's accuracy, speed, and scalability. As a result of these advanced techniques, HybridGNN achieved an area under the receiver operating characteristic curve (AUC-ROC) of 0.9715 using a dot-product classifier, outperforming several existing methods and underscoring its potential as a robust and accurate tool for predicting MDAs. AVAILABILITY: Code and data are freely available at https://github.com/mbasharatahmad/HybridGNN-miRNA-disease/.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.